在患有高海拔肺的患者中,细胞因子水平升高
Binyun Liu1, Quzong Zhaxi2, Zhuoga Danzeng3
1People's Hospital of Xizang Autonomous Region, Lhasa, China; Key Laboratory of Translational Medicine for Human Adaptation to the High-Altitude of Tibet Autonomous Region, People's Hospital of Xizang Autonomous Region, Lhasa, China.
Cytokine
|August 2, 2025
概括
高海拔肺 (HAPE) 涉及免疫系统的调节失调. 升高的介质素-2 (IL-2),介质素-10 (IL-10) 和瘤亡因子 (TNF) 表示HAPE风险和潜在的治疗点.
科学领域:
- 高度医学 高度医学
- 免疫学 免疫学 免疫学
- 肺部医学 肺部医学
背景情况:
- 免疫系统适应高海拔是至关重要的,但对于高海拔肺 (HAPE) 了解甚少.
- 研究免疫调节在HAPE病原发生中的作用对于了解疾病机制至关重要.
研究的目的:
- 探索免疫调节对高海拔肺 (HAPE) 病变的影响.
- 为了评估HAPE患者的血清细胞因子水平,与健康的适应者相比.
主要方法:
- 细胞计数珠阵列 (CBA) 技术被用于量化血清细胞因子概况.
- 在28名HAPE患者和25名健康对照中测量了7种T辅助细胞 (Th) 1/2/17细胞因子,MCP-1,IL-8和IL-1β.
主要成果:
- 与健康个体相比,HAPE患者的IL-2,IL-10和TNF血清度显著更高 (P < 0.001).
- 这些细胞因子的组合显示出HAPE预测的高诊断能力 (AUC = 0.98).
- 两组之间IL-6,IL-8,IFN-γ,IL-4,IL-17A,MCP-1和IL-1β水平没有发现显著差异.
结论:
- 升高的IL-2,IL-10和TNF水平表明免疫失调是HAPE的关键驱动因素.
- 这些细胞因子可能有助于预测HAPE的临床风险,并指导向治疗,例如抗TNF药物.
- 需要进一步的研究来阐明缺氧特异性细胞因子网络,并验证在高度环境中的干预措施.
相关概念视频
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
01:29Pneumonia II: Pathophysiology
559
The pathophysiology of pneumonia involves the following steps:
559
01:28Pleural Effusion II: Symptoms and Management
269
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
269
01:20COPD: Pathogenesis and Clinical Features
525
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
525
01:30Acute Respiratory Failure-III
321
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
321
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K